From arrhythmia initiation to progression: uncovering the molecular mechanisms stabilizing cardiac arrhythmias using a computational-experimental approach

Hartritmestoornissen zijn een belangrijke doodsoorzaak. Om tot betere behandelingen te komen worden in dit onderzoek nieuwe computermodellen ontwikkeld om veranderingen in de elektrische eigenschappen van het hart over milliseconden tot dagen te bestuderen. Deze veranderingen kunnen bijdragen aan de stabilisatie van ritmestoornissen en de huidige therapie negatief beïnvloeden.

Producten

Titel: Mind the gap: leak currents and induced pluripotentstem cell-derived cardiomyocytes in translational cardiac electrophysiology
Auteur: Heijman J, Christ T
Magazine: Europace
Titel: In silico analysis of the dynamic regulation of cardiac electrophysiology by K<sub>v</sub> 11.1ion-channel trafficking
Auteur: Meier S, Grundland A, Dobrev D, Volders PGA, Heijman J
Magazine: J Physiol
Titel: CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2
Auteur: Cachorro E, Günscht M, Schubert M, Sadek MS, Siegert J, Dutt F, BauermeisterC, Quickert S, Berning H, Nowakowski F, Lämmle S, Firneburg R, Luo X, Künzel SR,Klapproth E, Mirtschink P, Mayr M, Dewenter M, Vettel C, Heijman J, Lorenz K,Guan K, El-Armouche A, Wagner M, Kämmerer S
Magazine: Circ Res
Titel: Electrophysiological and calcium-handling development during long-termculture of human-induced pluripotent stem cell-derived cardiomyocytes
Auteur: Seibertz F, Sutanto H, Dülk R, Pronto JRD, Springer R, Rapedius M, LiutkuteA, Ritter M, Jung P, Stelzer L, Hüsgen LM, Klopp M, Rubio T, Fakuade FE, MasonFE, Hartmann N, Pabel S, Streckfuss-Bömeke K, Cyganek L, Sossalla S, Heijman J,Voigt N
Magazine: Basic Res Cardiol
Titel: Why translation from basicdiscoveries to clinical applications is so difficult for atrial fibrillation andpossible approaches to improving it
Auteur: Nattel S, Sager PT, Hüser J, Heijman J, Dobrev D
Magazine: Cardiovasc Res
Begin- en eindpagina: 1616-1631
Titel: Cellular Mechanisms of the Anti-Arrhythmic Effect ofCardiac PDE2 Overexpression
Auteur: Wagner M, Sadek MS, Dybkova N, Mason FE, Klehr J, Firneburg R, Cachorro E,Richter K, Klapproth E, Kuenzel SR, Lorenz K, Heijman J, Dobrev D, El-ArmoucheA, Sossalla S, Kämmerer S
Magazine: Int J Mol Sci
Titel: Dual effects of the small-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> current on human atrial electrophysiology and Ca<sup>2+</sup>-driven arrhythmogenesis: an in silico study
Auteur: Herrera NT, Zhang X, Ni H, Maleckar MM, Heijman J, Dobrev D, Grandi E,Morotti S
Magazine: Am J Physiol Heart Circ Physiol
Titel: Multi-Scale Computational Modeling of Spatial Calcium Handling From Nanodomainto Whole-Heart: Overview and Perspectives
Auteur: Colman MA, Alvarez-Lacalle E, Echebarria B, Sato D, Sutanto H, Heijman J
Magazine: Front Physiol
Titel: <i>Insilico</i> Identification of Disrupted Myocardial Calcium Homeostasis as Proarrhythmic Trigger in Arrhythmogenic Cardiomyopathy
Auteur: Lyon A, van Opbergen CJM, Delmar M, Heijman J, van Veen TAB
Magazine: Front Physiol
Titel: Recent Advances in Antiarrhythmic Drug Therapy
Auteur: Saljic A, Heijman J, Dobrev D
Magazine: Drugs
Titel: 25 years of basic andtranslational science in EP Europace: novel insights into arrhythmia mechanismsand therapeutic strategies
Auteur: Remme CA, Heijman J, Gomez AM, Zaza A, Odening KE
Magazine: Europace
Titel: Molecular determinants and therapeutic potential of focal ectopic activity: more than meets the Iti
Auteur: Heijman J, Dobrev D
Magazine: Eur Heart J
Titel: Commentary: EP-PINNs: Cardiac electrophysiologycharacterisation using physics-informed neural networks
Auteur: Meier S, Heijman J
Magazine: Front Cardiovasc Med
Titel: Stretching the limits of antiarrhythmic drugtherapy: The promise of small-conductance calcium-activated potassium channelblockers
Auteur: Heijman J, Rahm AK, Dobrev D
Magazine: Int J Cardiol Heart Vasc
Titel: Determinants and therapeutic potential of calcium handling abnormalities in atrial fibrillation: what can we learn from computer models?
Auteur: Heijman J, Dobrev D
Magazine: J Physiol
Titel: Emerging Antiarrhythmic Drugs for AtrialFibrillation
Auteur: Saljic A, Heijman J, Dobrev D
Magazine: Int J Mol Sci
Titel: Computationalmodels of atrial fibrillation: achievements, challenges, and perspectives forimproving clinical care
Auteur: Heijman J, Sutanto H, Crijns HJGM, Nattel S, Trayanova NA
Magazine: Cardiovasc Res
Titel: The Atrium in AtrialFibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates
Auteur: Cunha PS, Laranjo S, Heijman J, Oliveira MM
Magazine: Front Cardiovasc Med
Titel: Enhanced Ca<sup>2+</sup>-Dependent SK-Channel Gating and Membrane Trafficking in Human Atrial Fibrillation
Auteur: Heijman J, Zhou X, Morotti S, Molina CE, Abu-Taha IH, Tekook M, Jespersen T,Zhang Y, Dobrev S, Milting H, Gummert J, Karck M, Kamler M, El-Armouche A,Saljic A, Grandi E, Nattel S, Dobrev D
Magazine: Circ Res
Titel: P2X7 receptors: central drivers of the neuro-cardiac link between atrial fibrillation and depression?
Auteur: Saljic A, Heijman J
Magazine: Europace

Kenmerken

Projectnummer:
09150171910029
Looptijd: 92%
2021
2027
Gerelateerde subsidieronde:
Projectleider en penvoerder:
Heijman
Verantwoordelijke organisatie:
Medical University of Graz